Widely available and nearly unlimited compute resources, coupled with the availability of sophisticated algorithms, are opening the door to adaptive testing. But the speed at which this testing ...
SEATTLE, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune ...
Adaptive test is starting to gain traction for high-performance computing and AI chips as test programs that rely on static limits and fixed test sequences reach their practical limits. The growing ...
High performance computing has entered a new phase, one where the chips inside a machine can reshape themselves around the code they are running. Instead of simply stacking more processors and drawing ...
Adaptive Biotechnologies Corporation announced that as of January 1, 2025, the new Medicare Clinical Laboratory Fee Schedule includes a payment rate of $2,007 for its clonoSEQ test used for assessing ...